菲莫国际：提出三年规划，聚焦新烟成长

Investment Rating - The industry investment rating is "Positive" [2] Core Insights - The report highlights that Philip Morris International (PMI) has set a three-year growth plan focusing on new tobacco products, targeting a revenue CAGR of 6%-8% and an operating profit CAGR of 8%-10% from 2026 to 2028 [3] - PMI's revenue for 2025 reached $40.65 billion, a year-on-year increase of 7.3%, with new tobacco product revenue at $16.85 billion, up 15.0% [2][3] - The report anticipates significant growth in the U.S. market, particularly with the launch of IQOS ILUMA, which is expected to stimulate the heat-not-burn (HNB) segment [3] Revenue and Market Performance - In 2025, PMI's total revenue was $40.65 billion, with Q4 revenue at $10.36 billion, reflecting a 6.8% year-on-year increase [2] - The HNB segment achieved a global market share of approximately 76%, with annual sales of 155.1 billion units, marking an 11.0% increase [4] - In Q4, HNB sales reached 38.4 billion units, a 7.5% increase year-on-year, with Japan's HNB penetration rate reaching 32.6% [4] Product Growth and Strategy - The report notes that sales of oral tobacco and vaping products increased by 18.5% and 100% year-on-year, respectively, with Q4 growth rates of 7.3% and 91.4% [5] - The U.S. oral tobacco market, particularly the ZYN brand, continues to grow rapidly, maintaining a market share close to two-thirds [5] - PMI's vaping product VEEV has launched in 47 markets, showing a doubling growth trend and achieving the top market share in eight markets [5]